Learning and behavioural issues in DMD/BMD
This EU-funded project connecting 19 partners aims to address a crucial aspect of DMD and BMD that was already recognised in 1861, when Duchenne de Boulogne first described the neuromuscular condition.
Brain involvement received less attention
However, in the last few decades, most of the efforts have focused on improving outcomes related to muscle weakness, whilst brain involvement has received less attention. The BIND project is the first project of this scale to improve characterisation of brain involvement in Duchenne and Becker Muscular Dystrophy (DMD and BMD respectively), a previously overlooked field.
Benefit the broader neuromuscular field
As well as being of great importance for the Duchenne and Becker community, this project might also benefit the broader neuromuscular and neurodevelopmental field. Brain comorbidity neurobiology is poorly understood, and standards of care not widely disseminated and implemented. This four-year project describing the contribution of a specific protein (dystrophin) to brain function could be of crucial value for the broader neurobiology field, including autistic spectrum disorders.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 847826.